HS 1211-20-90-00 – Other

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

Plants and parts of plants (including seeds and fruits), of a kind used primarily in perfumery, in pharmacy or for insecticidal, fungicidal or similar purposes, fresh, chilled, frozen or dried, whether or not cut, crushed or powdered. › Ginseng roots › Other

MFN duty rate

Free

GST

5%

Unit of measure

KGM

Other

Estimate duty & taxes · Get classification help

Preferential tariff rates

• Costa Rica (CRT): Free
• Israel (CIAT): Free
• Jordan (JT): Free
• MXT/CUSMA (Mexico): Free
• CPTPP: Free
• Colombia: Free
• Korea: Free
• Chile: Free
• GPT: Free
• Iceland: Free
• CETA: Free
• Panama (PAT): Free
• UK: Free
• UST/CUSMA (US): Free
• CPTPP – United Kingdom (CPUKT): Free
• Peru: Free
• LDCT: Free
• Ukraine: Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• Switzerland–Liechtenstein (SLT): Free
• Honduras (HNT): Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Other (HS 1211-20-90-00)?

The T2026-2 MFN rate for tariff item 1211.20.90 is Free. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 1211-20-90-00 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. This item is not on any US surtax schedule in force in TariffPlus surtax data (checked against CBSA). GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 1211-20-90-00?

Costa Rica (CRT): Free; Israel (CIAT): Free; Jordan (JT): Free; MXT/CUSMA (Mexico): Free; CPTPP: Free; Colombia: Free; Korea: Free; Chile: Free; GPT: Free; Iceland: Free; CETA: Free; Panama (PAT): Free; UK: Free; UST/CUSMA (US): Free; CPTPP – United Kingdom (CPUKT): Free; Peru: Free; LDCT: Free; Ukraine: Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; Switzerland–Liechtenstein (SLT): Free; Honduras (HNT): Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.